Tenet Healthcare (THC) Tops Q2 EPS by 41c, provides guidance
Get Alerts THC Hot Sheet
Price: $286.97 +7.60%
Financial Fact:
Continuing operations: -0.09
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Continuing operations: -0.09
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Tenet Healthcare (NYSE: THC) reported Q2 EPS of $2.31, $0.41 better than the analyst estimate of $1.90. Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $4.99 billion.
GUIDANCE:
Tenet Healthcare sees Q3 2024 EPS of $2.16-$2.58, versus the consensus of $1.67. Tenet Healthcare sees Q3 2024 revenue of $5-5.1 billion, versus the consensus of $4.889 billion.
For earnings history and earnings-related data on Tenet Healthcare (THC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbnb (ABNB) call put ratio 1 call to 1.3 puts into quarter results
- L.B. Foster (FSTR) Reports In-Line Q3 EPS ; Offers Guidance
- XPEL, Inc. (XPEL) Tops Q3 EPS by 4c, Misses on Revenue; Offers Q4 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share